Comparison of Carbetocin vs Oxytocin for prevention of haemorrhage after delivery in women undergoing Caesarean sectio
Phase 3
- Conditions
- Health Condition 1: O721- Other immediate postpartum hemorrhage
- Registration Number
- CTRI/2022/06/043237
- Lead Sponsor
- IQ City Medical College Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1.Age 21 to 45 years
2.Emergency or elective Caesarean section
3.Singleton pregnancy
Exclusion Criteria
1.Contraindication for carbetocin and oxytocin
known allergy or hypersensitivity to carbetocin or oxytocin
2.Cases of coagulopathy
3.Multifoetal gestation
4.Medical diseases as cardiac, hypertension, liver, renal or endocrine diseases
5.Uterine fibroids
6.Suspected placental pathology (placenta accreta, praevia or abruption)
7.General anaesthesia
8.Classical uterine incision
9.Those who did not give consent
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Volume of blood loss <br/ ><br>Use of additional uterotonicsTimepoint: First 24 hours post-operative
- Secondary Outcome Measures
Name Time Method change in blood pressureTimepoint: after one hour of drug administration;change in haemoglobinTimepoint: 24 hours after lscs;change in pulse rateTimepoint: after one hour of drug administration;need of blood transfusionTimepoint: during first 24 hours post operative